Clinical trials
Transplantation clinical trials
Below are recruiting transplantation clinical trials, each written for real people, not researchers. We’re tracking 1,452 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT03689842Recruiting
Testing living-donor uterine transplant for MRKH
This study tests whether transplanting a uterus from a living related donor can be done safely and can help patients with MRKH type I achieve pregnancy. It also checks risks and safety issues for both the donor and recipient.
SuresnesAges 18–65 - NCT07332260RecruitingPhase 1
Fecal transplant for Alzheimer's disease
This study tests whether a fecal transplant (transferring healthy bacteria from a donor's stool into your colon) can improve memory and thinking in people with mild to moderate Alzheimer's. You would receive the transplant via colonoscopy and have follow-up brain scans.
Tromsø, TromsAges 18 years+ - NCT07329296Enrolling by invitation
Liver regeneration after living donor transplant study
This study looks at how the donor's liver grows back after donating a part of it for a living donor liver transplant. If you have donated a part of your liver between 2004 and 2026, joining could help doctors learn more about liver healing.
Rotterdam, South HollandAges 18–60 - NCT05516472RecruitingEarly Phase 1
Fecal transplant study for people with frequent kidney stones
This trial tests whether transplanting donated stool microbiome (fecal microbiota transplantation) can change gut bacteria and help reduce harm from frequent kidney stones. You would provide urine and stool samples and have follow-up checks to watch for side effects.
Park City, UtahAges 18–69 - NCT06776029RecruitingPhase 2
Fecal transplant for radiation-induced rectal bleeding
This study tests whether a fecal (stool) transplant can help heal rectal damage caused by pelvic radiation. The treatment may decrease bleeding and improve symptoms for people whose supportive care hasn't worked well.
Guangzhou, GuangdongAges 18–75 - NCT05803993Recruiting
Fecal transplant to ease constipation in irritable bowel syndrome
This trial tests whether transferring stool bacteria to the gut (fecal microbiota transplantation) can reduce symptoms of irritable bowel syndrome with constipation. It may help by changing the gut microbiome, but you must meet safety and health requirements.
RomaAges 18 years+ - NCT05803980Recruiting
Fecal transplant to ease IBS diarrhea symptoms
This study tests whether fecal microbiota transplantation (a stool-based treatment to change gut bacteria) can reduce symptoms of irritable bowel syndrome (IBS) that comes with diarrhea. You may be eligible if you’re an adult with diarrhea-predominant IBS and recent colonoscopy results that rule out other intestinal diseases.
RomaAges 18 years+ - NCT07315165RecruitingPhase 2
Liquid nutrition vs. standard care after stem cell transplant
This trial tests whether giving liquid nutrition through a tube (enteral nutrition) can improve recovery after a stem cell transplant for a blood disorder, compared to standard care where patients eat normally or use other nutrition support.
Omaha, NebraskaAges 19 years+ - NCT07301866RecruitingPhase 1/Phase 2
Testing an improved dose of UM171 for cord blood transplant
This trial tests a higher dose of UM171 to make cord blood transplants safer and more effective for people with certain blood cancers or bone marrow diseases. It aims to help patients who don't have a suitable donor.
Montreal, QuebecAges 18–67 - NCT07304466Recruiting
Terlipressin and somatostatin for portal pressure in liver transplant
This study tests two medicines (terlipressin and somatostatin) to see how they affect pressure in the portal vein during liver transplant. It may help people with high portal pressure who are getting a right lobe living donor liver transplant.
Istanbul, BagcilarAges 18–70 - NCT07304232RecruitingPhase 2
Chidamide after stem cell transplant for AML
This trial tests a drug called chidamide (Cidabenamide) as maintenance therapy after a stem cell transplant for people with intermediate or high-risk AML. The goal is to see if it helps prevent the leukemia from coming back.
Shijiazhuang, HebeiAges 18–75 - NCT07288281Recruiting
Preoperative Clear Fluid Fasting in Liver Transplant
This trial looks at how long before surgery patients waiting for a liver transplant can drink clear fluids, like water. The goal is to find a safer or more comfortable fasting time.
Warsaw, WarszawaAges 18 years+ - NCT07294547Recruiting
Comparing two antivirals for kidney transplant patients
This trial compares two antiviral drugs, valacyclovir and valganciclovir, to see if valacyclovir works as well as valganciclovir for preventing CMV and EBV infections after a kidney transplant.
TaipeiAges 3 years+ - NCT07294183Recruiting
Emotion-focused support after kidney transplant
This study tests a program designed to help people who have had a kidney transplant learn new ways to manage their emotions and feel better overall. It uses talk-based activities to support your well-being after transplant.
AntalyaAges 18 years+ - NCT07290777RecruitingPhase 2
Study of Vel-101 to prevent kidney transplant rejection
This trial tests a new medicine called VEL-101, which is added to standard anti-rejection drugs, to see if it helps prevent the body from rejecting a new kidney. It is for adults receiving a kidney from a deceased or non-identical living donor.
Dallas, TexasAges 18 years+ - NCT07284641RecruitingPhase 2
Stem cell transplant for immune disorders
This trial tests a stem cell transplant to treat common variable immunodeficiency (CVID) and other immune problems. It aims to replace a faulty immune system with a healthy one from a donor.
Pittsburgh, PennsylvaniaAges 5–40 - NCT07286318RecruitingEarly Phase 1
Niacinamide cream for skin cancer prevention in transplant patients
This trial tests if a daily cream with 5% niacinamide (a form of vitamin B3) can help prevent skin cancer in people who have had an organ transplant. You will apply the cream to your skin and also use sunscreen every day.
Pittsburgh, PennsylvaniaAges 18 years+ - NCT07279350Recruiting
Health advocate support for children after liver transplant
This study tests whether having a health advocate helps families manage care for their child after a liver transplant. The advocate will provide support and resources to reduce stress and improve the child's recovery.
San Francisco, CaliforniaAges birth–18 years - NCT02007356RecruitingPhase 2
Donor immune cell infusions for viral infections after stem cell transplant
This trial studies whether directly infusing donor-made immune cells (virus-fighting T-cells) is safe and feasible in people who still have viral infections after a stem cell transplant. It may help your body control infections from adenovirus, CMV, or EBV when standard antiviral treatments aren’t working.
BaselAges 18–65 - NCT07275632RecruitingPhase 1/Phase 2
Testing vonoprazan to prevent delayed kidney function after transplant
This trial tests whether a medicine called vonoprazan fumarate can help prevent delayed kidney function after a first kidney transplant from a deceased donor. It is for people who are ready to follow standard post-transplant care.
ChongqingAges 18 years+ - NCT07276100RecruitingPhase 2
Fecal transplant to help liver cancer that worsened on first treatment
This trial tests whether transplanting healthy stool bacteria into your gut can help your own immune system fight liver cancer that has stopped responding to the standard first combination treatment (atezolizumab + bevacizumab). It is for patients whose liver cancer has started growing quickly despite that treatment.
Bologna, BOAges 18 years+ - NCT05855083RecruitingPhase 2
Narsoplimab for high-risk TMA after bone marrow transplant
This trial studies the medicine narsoplimab in children who develop a serious complication called HSCT-TMA after a bone marrow transplant. It aims to improve safety and effectiveness for high-risk cases where the condition is ongoing or causing organ problems.
San Diego, CaliforniaAges 4 weeks–17 years - NCT07266467RecruitingPhase 4
Preventing CMV After First Kidney Transplant
This trial tests a new medicine, Leymovir, against a standard one, Valganciclovir, to prevent a common virus infection (CMV) after a first kidney transplant. It may help you avoid CMV-related illness.
Xi'an, ShaanxiAges 18 years+ - NCT06899867Recruiting
Comparing heart monitoring methods during liver transplant
This trial compares two ways to monitor how well your heart is pumping during liver transplant surgery. One method uses a thin tube in your blood vessels, and the other uses an ultrasound probe placed in your food pipe.
France, LyonAges 18 years+
Hear when a new Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for transplantation?
- Yes. Clin2 currently lists 1,452 recruiting transplantation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a transplantation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a transplantation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.